Adjunctive Everolimus Therapy for Treatment-resistant Focal-onset Seizures Associated with Tuberous Sclerosis: A Phase 3, Randomised, Double-blind, Placebo-controlled Study

Journal Title: UNKNOWN - Year 2018, Vol 24, Issue 2

Abstract

.

Authors and Affiliations

Mustafa Karaoğlan

Keywords

Related Articles

Transthyretin-Related Familial Amyloid Polyneuropathy: In the Light of New Developments

Transthyretin-related familial amyloid polyneuropathy (TTR-FAP) is caused by gain-of-toxic-function of TTR, which dissociates from its native tetramer form to a monomer form and aggregates in several tissues and organs....

Experience of Intravenous Thrombolytic Treatment in Sanliurfa: A Prospective Study

Objective: Stroke ranks second among the diseases that cause death and third among the causes of disability in Turkey. An average of 1.9 million neurons die every minute due to acute ischemic stroke and therefore ‘time i...

Frequency of Falls and Relationship Between Falls, Socio-demographic and Clinical Factors in Idiopathic Parkinson’s Disease

Objective: Falls are major problems for people with Parkinson’s disease. This study aimed to determine fall frequency, and the relation of socio-demographic and clinical factors in idiopathic Parkinson’s disease (IPH). M...

Download PDF file
  • EP ID EP368887
  • DOI 10.4274/tnd.78466
  • Views 86
  • Downloads 0

How To Cite

Mustafa Karaoğlan (2018). Adjunctive Everolimus Therapy for Treatment-resistant Focal-onset Seizures Associated with Tuberous Sclerosis: A Phase 3, Randomised, Double-blind, Placebo-controlled Study. UNKNOWN, 24(2), 193-194. https://www.europub.co.uk/articles/-A-368887